B. Metzler seel. Sohn & Co’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $674K | Buy |
|
|||||
|
2025
Q1 | $547K | Sell |
|
|||||
|
2024
Q4 | $689K | Buy |
|
|||||
|
2024
Q3 | $553K | Buy |
|
|||||
|
2024
Q2 | $347K | Buy |
|
|||||
|
2024
Q1 | $331K | Buy |
|
|||||
|
2023
Q4 | $257K | Sell |
|
|||||
|
2023
Q3 | $486K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $233K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $428K | Buy |
|
|||||
|
2021
Q1 | $302K | Buy |
|
|||||
|
2020
Q4 | $231K | Buy |
|